| Full Name | Stephanie Shu |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 90 B Ave, Lake Oswego, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265813117 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 71487 (California) | Secondary |
| 183500000X | Pharmacist | 0015751 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Shu, 90 B Ave, Lake Oswego, OR 97034-3131 Ph: () - | Stephanie Shu, 90 B Ave, Lake Oswego, OR 97034-3131 Ph: (503) 697-0990 |
News Archive
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 53-61(9); DOI https://doi.org/10.15212/CVIA.2019.0012, Molly Pantelic, Milan Pantelic, MD, Todd Pietila, Marianne Rollet, Eric Myers,Thomas Song, MD, William W. O'Neill, MD and Dee Dee Wang, MD, FACC, FASE, FSCCT from the Center for Structural Heart Disease, Division of Cardiology, Henry Ford Health System, Detroit, MI, USA; Department of Radiology, Henry Ford Health System, Detroit, MI, USA; Materialise, Plymouth, MI, USA and Henry Ford Innovation Institute, Henry Ford Health System, Detroit, MI, USA consider using 3D-printed models to advance clinical care.
As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.
TapImmune, Inc., is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida, a leading, non-profit biomedical research institute, forming a partnership to advance TapImmune's proprietary, cancer vaccines into Phase II human clinical trials for the treatment of breast and ovarian cancers.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
In a study to investigate the detection by MRI of six kinds of positively-charged magnetic iron oxide nanoparticles designed to help monitor transplanted islet cells, a team of Japanese researchers found that the charged nanoparticles they developed transduced into cells and could be visualized by MRI while three kinds of commercially available nanoparticles used for controls could not.
› Verified 7 days ago
Katherine Eva Blezinski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17779 Lower Boones Ferry Rd, Lake Oswego, OR 97035 Phone: 503-675-2509 Fax: 503-675-2512 | |
Charles Gutin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16303 Bryant Rd, Lake Oswego, OR 97035 Phone: 503-636-5697 Fax: 503-699-7990 | |
Mr. Kenneth Andrew Ernst, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17850 Lower Boones Ferry Rd, Lake Oswego, OR 97035 Phone: 971-233-0113 | |
Mr. James A Lampert, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 90 B Ave, Lake Oswego, OR 97034 Phone: 503-697-0990 | |
Kenneth Epley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1399 Mcvey Ave, Lake Oswego, OR 97034 Phone: 503-635-5211 | |
Tina Huynh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17779 Lwr Boones Fry Rd, Lake Oswego, OR 97035 Phone: 503-675-2500 | |
Dr. Aaron Bohn, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6025 Jean Rd, Lake Oswego, OR 97035 Phone: 503-303-7373 Fax: 503-344-4996 |